295 related articles for article (PubMed ID: 15289504)
41. Edelfosine and miltefosine effects on lipid raft properties: membrane biophysics in cell death by antitumor lipids.
Castro BM; Fedorov A; Hornillos V; Delgado J; Acuña AU; Mollinedo F; Prieto M
J Phys Chem B; 2013 Jul; 117(26):7929-40. PubMed ID: 23738749
[TBL] [Abstract][Full Text] [Related]
42. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) promotes mitochondrial dysfunction and apoptosis induced by 7-hydroxystaurosporine and mitogen-activated protein kinase kinase inhibitors in human leukemia cells that ectopically express Bcl-2 and Bcl-xL.
Dai Y; Dent P; Grant S
Mol Pharmacol; 2003 Dec; 64(6):1402-9. PubMed ID: 14645670
[TBL] [Abstract][Full Text] [Related]
43. Messengers of cell death: apoptotic signaling in health and disease.
Rossi D; Gaidano G
Haematologica; 2003 Feb; 88(2):212-8. PubMed ID: 12604411
[TBL] [Abstract][Full Text] [Related]
44. CD95 death-inducing signaling complex formation and internalization occur in lipid rafts of type I and type II cells.
Eramo A; Sargiacomo M; Ricci-Vitiani L; Todaro M; Stassi G; Messina CG; Parolini I; Lotti F; Sette G; Peschle C; De Maria R
Eur J Immunol; 2004 Jul; 34(7):1930-40. PubMed ID: 15214041
[TBL] [Abstract][Full Text] [Related]
45. Differential targets and subcellular localization of antitumor alkyl-lysophospholipid in leukemic versus solid tumor cells.
Nieto-Miguel T; Gajate C; Mollinedo F
J Biol Chem; 2006 May; 281(21):14833-40. PubMed ID: 16540473
[TBL] [Abstract][Full Text] [Related]
46. Induction of apoptosis and potentiation of TNF- and Fas-mediated apoptosis in U937 cells by the xanthogenate compound D609.
Pörn-Ares MI; Chow SC; Slotte JP; Orrenius S
Exp Cell Res; 1997 Aug; 235(1):48-54. PubMed ID: 9281351
[TBL] [Abstract][Full Text] [Related]
47. By activating Fas/ceramide synthase 6/p38 kinase in lipid rafts, stichoposide D inhibits growth of leukemia xenografts.
Yun SH; Park ES; Shin SW; Ju MH; Han JY; Jeong JS; Kim SH; Stonik VA; Kwak JY; Park JI
Oncotarget; 2015 Sep; 6(29):27596-612. PubMed ID: 26318294
[TBL] [Abstract][Full Text] [Related]
48. Fas/CD95 down-regulation in lymphoma cells through acquired alkyllysophospholipid resistance: partial role of associated sphingomyelin deficiency.
van Blitterswijk WJ; Klarenbeek JB; van der Luit AH; Alderliesten MC; van Lummel M; Verheij M
Biochem J; 2009 Dec; 425(1):225-34. PubMed ID: 19824885
[TBL] [Abstract][Full Text] [Related]
49. Lipid rafts, endoplasmic reticulum and mitochondria in the antitumor action of the alkylphospholipid analog edelfosine.
Gajate C; Mollinedo F
Anticancer Agents Med Chem; 2014 May; 14(4):509-27. PubMed ID: 24628241
[TBL] [Abstract][Full Text] [Related]
50. Beyond the "Lock and Key" Paradigm: Targeting Lipid Rafts to Induce the Selective Apoptosis of Cancer Cells.
Alves ACS; Dias RA; Kagami LP; das Neves GM; Torres FC; Eifler-Lima VL; Carvalho I; de Miranda Silva C; Kawano DF
Curr Med Chem; 2018; 25(18):2082-2104. PubMed ID: 29332565
[TBL] [Abstract][Full Text] [Related]
51. Involvement of lipid rafts in the localization and dysfunction effect of the antitumor ether phospholipid edelfosine in mitochondria.
Mollinedo F; Fernández M; Hornillos V; Delgado J; Amat-Guerri F; Acuña AU; Nieto-Miguel T; Villa-Pulgarín JA; González-García C; Ceña V; Gajate C
Cell Death Dis; 2011 May; 2(5):e158. PubMed ID: 21593790
[TBL] [Abstract][Full Text] [Related]
52. Liposomal ET-18-OCH(3) induces cytochrome c-mediated apoptosis independently of CD95 (APO-1/Fas) signaling.
Cuvillier O; Mayhew E; Janoff AS; Spiegel S
Blood; 1999 Nov; 94(10):3583-92. PubMed ID: 10552970
[TBL] [Abstract][Full Text] [Related]
53. Involvement of c-Jun NH2-terminal kinase activation and c-Jun in the induction of apoptosis by the ether phospholipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
Gajate C; Santos-Beneit A; Modolell M; Mollinedo F
Mol Pharmacol; 1998 Apr; 53(4):602-12. PubMed ID: 9547349
[TBL] [Abstract][Full Text] [Related]
54. Clusters of apoptotic signaling molecule-enriched rafts, CASMERs: membrane platforms for protein assembly in Fas/CD95 signaling and targets in cancer therapy.
Mollinedo F; Gajate C
Biochem Soc Trans; 2022 Jun; 50(3):1105-1118. PubMed ID: 35587168
[TBL] [Abstract][Full Text] [Related]
55. Lipid rafts and raft-mediated supramolecular entities in the regulation of CD95 death receptor apoptotic signaling.
Gajate C; Mollinedo F
Apoptosis; 2015 May; 20(5):584-606. PubMed ID: 25702154
[TBL] [Abstract][Full Text] [Related]
56. Posttranscriptional regulation of Fas (CD95) ligand killing activity by lipid rafts.
Nachbur U; Kassahn D; Yousefi S; Legler DF; Brunner T
Blood; 2006 Apr; 107(7):2790-6. PubMed ID: 16332972
[TBL] [Abstract][Full Text] [Related]
57. Lipid rafts and clusters of apoptotic signaling molecule-enriched rafts in cancer therapy.
Mollinedo F; Gajate C
Future Oncol; 2010 May; 6(5):811-21. PubMed ID: 20465392
[TBL] [Abstract][Full Text] [Related]
58. Thymineless death in F10-treated AML cells occurs via lipid raft depletion and Fas/FasL co-localization in the plasma membrane with activation of the extrinsic apoptotic pathway.
Gmeiner WH; Jennings-Gee J; Stuart CH; Pardee TS
Leuk Res; 2015 Feb; 39(2):229-35. PubMed ID: 25510486
[TBL] [Abstract][Full Text] [Related]
59. Resistance to alkyl-lysophospholipid-induced apoptosis due to downregulated sphingomyelin synthase 1 expression with consequent sphingomyelin- and cholesterol-deficiency in lipid rafts.
Van der Luit AH; Budde M; Zerp S; Caan W; Klarenbeek JB; Verheij M; Van Blitterswijk WJ
Biochem J; 2007 Jan; 401(2):541-9. PubMed ID: 17049047
[TBL] [Abstract][Full Text] [Related]
60. Urokinase plasminogen activator receptor and/or matrix metalloproteinase-9 inhibition induces apoptosis signaling through lipid rafts in glioblastoma xenograft cells.
Chetty C; Lakka SS; Bhoopathi P; Gondi CS; Veeravalli KK; Fassett D; Klopfenstein JD; Dinh DH; Gujrati M; Rao JS
Mol Cancer Ther; 2010 Sep; 9(9):2605-17. PubMed ID: 20716639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]